These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 10047731)

  • 1. [Differentiation and function of bone cells induced by bone matrix proteins: osteopontin in bone remodeling].
    Uemura T; Nemoto A; Deng HY
    Tanpakushitsu Kakusan Koso; 1999 Feb; 44(2):143-8. PubMed ID: 10047731
    [No Abstract]   [Full Text] [Related]  

  • 2. Role of osteopontin in adhesion, migration, cell survival and bone remodeling.
    Standal T; Borset M; Sundan A
    Exp Oncol; 2004 Sep; 26(3):179-84. PubMed ID: 15494684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro and in vivo study on osteocyte-specific mechanical signaling pathways.
    Yang W; Kalajzic I; Lu Y; Guo D; Harris MA; Gluhak-Heinrich J; Bonewald LF; Feng JQ; Rowe DW; Harris SE
    J Musculoskelet Neuronal Interact; 2004 Dec; 4(4):386-7. PubMed ID: 15758272
    [No Abstract]   [Full Text] [Related]  

  • 4. Roles of osteopontin in bone remodeling.
    Heinegård D; Andersson G; Reinholt FP
    Ann N Y Acad Sci; 1995 Apr; 760():213-22. PubMed ID: 7540374
    [No Abstract]   [Full Text] [Related]  

  • 5. Osteopontin-deficient bone cells are defective in their ability to produce NO in response to pulsatile fluid flow.
    Denhardt DT; Burger EH; Kazanecki C; Krishna S; Semeins CM; Klein-Nulend J
    Biochem Biophys Res Commun; 2001 Oct; 288(2):448-53. PubMed ID: 11606063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Integrin signal transduction via FAK in osteoblasts--early differentiation triggered by osteopontin].
    Nemoto A; Uemura T
    Seikagaku; 1999 Feb; 71(2):140-5. PubMed ID: 10200608
    [No Abstract]   [Full Text] [Related]  

  • 7. Integrin-extracellular matrix interactions in connective tissue remodeling and osteoblast differentiation.
    Globus RK; Moursi A; Zimmerman D; Lull J; Damsky C
    ASGSB Bull; 1995 Oct; 8(2):19-28. PubMed ID: 11538547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osteopontin: role in cell signaling and cancer progression.
    Rangaswami H; Bulbule A; Kundu GC
    Trends Cell Biol; 2006 Feb; 16(2):79-87. PubMed ID: 16406521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro and in vivo effects of the overexpression of osteopontin on osteoblast differentiation using a recombinant adenoviral vector.
    Kojima H; Uede T; Uemura T
    J Biochem; 2004 Sep; 136(3):377-86. PubMed ID: 15598896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Osteopontin receptors and signal transduction].
    Yokosaki Y; Higashikawa F
    Nihon Rinsho; 2005 Oct; 63 Suppl 10():613-7. PubMed ID: 16279710
    [No Abstract]   [Full Text] [Related]  

  • 11. Type I collagen-induced osteoblastic differentiation of bone-marrow cells mediated by collagen-alpha2beta1 integrin interaction.
    Mizuno M; Fujisawa R; Kuboki Y
    J Cell Physiol; 2000 Aug; 184(2):207-13. PubMed ID: 10867645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osteopontin: roles in implantation and placentation.
    Johnson GA; Burghardt RC; Bazer FW; Spencer TE
    Biol Reprod; 2003 Nov; 69(5):1458-71. PubMed ID: 12890718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteopontin-induced migration of human mammary epithelial cells involves activation of EGF receptor and multiple signal transduction pathways.
    Tuck AB; Hota C; Wilson SM; Chambers AF
    Oncogene; 2003 Feb; 22(8):1198-205. PubMed ID: 12606946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Osteopontin is a negative regulator of proliferation and differentiation in MC3T3-E1 pre-osteoblastic cells.
    Huang W; Carlsen B; Rudkin G; Berry M; Ishida K; Yamaguchi DT; Miller TA
    Bone; 2004 May; 34(5):799-808. PubMed ID: 15121011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of requirement of osteopontin for inflammation, bone erosion, and cartilage damage in the K/BxN model of autoantibody-mediated arthritis.
    Jacobs JP; Pettit AR; Shinohara ML; Jansson M; Cantor H; Gravallese EM; Mathis D; Benoist C
    Arthritis Rheum; 2004 Aug; 50(8):2685-94. PubMed ID: 15334485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of growth factors on the production of osteopontin and osteocalcin.
    Davis J; Tucci M; Franklin L; Russell G; Benghuzzi H
    Biomed Sci Instrum; 2006; 42():31-6. PubMed ID: 16817581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cell biology of bone metabolism.
    Datta HK; Ng WF; Walker JA; Tuck SP; Varanasi SS
    J Clin Pathol; 2008 May; 61(5):577-87. PubMed ID: 18441154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Advances in the research of osteopontin].
    Cheng Y; Zeng FD
    Sheng Li Ke Xue Jin Zhan; 1999 Jul; 30(3):267-70. PubMed ID: 12532796
    [No Abstract]   [Full Text] [Related]  

  • 19. [Osteopontin and regulation of bone metabolism].
    Noda M; Kato N; Ezura Y
    Nihon Rinsho; 2005 Oct; 63 Suppl 10():605-7. PubMed ID: 16279708
    [No Abstract]   [Full Text] [Related]  

  • 20. Matricellular proteins: Extracellular modulators of bone development, remodeling, and regeneration.
    Alford AI; Hankenson KD
    Bone; 2006 Jun; 38(6):749-57. PubMed ID: 16412713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.